Immuno cellular therapeutics, ltd. – product pipeline review – 2012


Published on

2012 | ImmunoCellular Therapeutics, Ltd. – Product Pipeline

Published in: Health & Medicine, Business
  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Immuno cellular therapeutics, ltd. – product pipeline review – 2012

  1. 1. announces, The Latest market research report is available inits vast collection:ImmunoCellular Therapeutics, Ltd. – Product Pipeline Review– 2012You can also request for sample page of above mention reports onsample@aarkstore.comSummaryGlobal Market Direct’s pharmaceuticals report, “ImmunoCellular Therapeutics, Ltd. -Product Pipeline Review - 2012” provides data on the ImmunoCellularTherapeutics, Ltd.’s research and development focus. The report includesinformation on current developmental pipeline, complete with latest updates, andfeatures on discontinued and dormant projects.This report is built using data and information sourced from Global Markets Direct’sproprietary databases, ImmunoCellular Therapeutics, Ltd.’s corporate website, SECfilings, investor presentations and featured press releases, both fromImmunoCellular Therapeutics, Ltd. and industry-specific third party sources, puttogether by Global Markets Direct’s team.Scope- ImmunoCellular Therapeutics, Ltd. - Brief ImmunoCellular Therapeutics, Ltd.overview including business description, key information and facts, and its locationsand subsidiaries.- Review of current pipeline of ImmunoCellular Therapeutics, Ltd. humantherapeutic division.
  2. 2. - Overview of pipeline therapeutics across various therapy areas.- Coverage of current pipeline molecules in various stages of drug development,including the combination treatment modalities, across the globe.Table of contents:List of Tables 4List of Figures 5ImmunoCellular Therapeutics, Ltd. Snapshot 6ImmunoCellular Therapeutics, Ltd. Overview 6Key Information 6Key Facts 6ImmunoCellular Therapeutics, Ltd. – Research and Development Overview 7Key Therapeutic Areas 7ImmunoCellular Therapeutics, Ltd. – Pipeline Review 9Pipeline Products by Stage of Development 9Pipeline Products – Monotherapy 10ImmunoCellular Therapeutics, Ltd. – Pipeline Products Glance 11ImmunoCellular Therapeutics, Ltd. Clinical Stage Pipeline Products 11Phase II Products/Combination Treatment Modalities 11ImmunoCellular Therapeutics, Ltd. – Early Stage Pipeline Products 12Pre-Clinical Products/Combination Treatment Modalities 12ImmunoCellular Therapeutics, Ltd. – Drug Profiles 13ICT-037 13Product Description 13Mechanism of Action 13R&D Progress 13ICT-107 14Product Description 14Mechanism of Action 14R&D Progress 14ICT-109 16Product Description 16Mechanism of Action 16R&D Progress 16ICT-111 18
  3. 3. Product Description 18Mechanism of Action 18R&D Progress 18ICT-121 19Product Description 19Mechanism of Action 19List of FiguresList of Tables are also include.For more related Reports Plz follow The link:Product Pipeline Review – 2012 PipelineReview – 2012&PubId=&pagenum=1ImmunoCellular Therapeutics, Ltd. – Product Pipeline Review – 2012MannKind Corporation – Product Pipeline Review – 2012Mundipharma International Limited – Product Pipeline Review – 2012NewLink Genetics Corporation – Product Pipeline Review – 2012Orexo AB – Product Pipeline Review – 2012Paladin Labs Inc. – Product Pipeline Review – 2012Pharmos Corporation – Product Pipeline Review – 2012
  4. 4. POZEN Inc. – Product Pipeline Review – 2012QLT Inc. – Product Pipeline Review – 2012Shire Plc – Product Pipeline Review – 2012Search More Reports Related to This Category :Pharmaceuticals and Healthcare andHealthcare&PubId=&pagenum=1For More details Plz do contact :Aarkstore EnterpriseLavanyaPhone:08149852585Email: